We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock?
Read MoreHide Full Article
Key Takeaways
Nu Skin faces continued revenue pressure from weak demand in key mature markets.
Project Accelerate is driving cost savings through portfolio optimization and digital transitions.
Margin gains from efficiency and mix shifts may offset softer sales and support profitability.
Nu Skin Enterprises, Inc. ((NUS - Free Report) ) is likely to register a decline in the top line when it reports third-quarter 2025 earnings on Nov. 6. The Zacks Consensus Estimate for revenues is pegged at $374.2 million, indicating a decrease of 13% from the prior-year reported figure.
The consensus mark for earnings has remained unchanged in the past 30 days at 30 cents per share, which suggests an increase of 76.5% from the year-ago quarter’s reported figure.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin is likely to face continued revenue pressure when it reports third-quarter 2025 results, reflecting persistent macroeconomic and operational headwinds. The company has been grappling with weakness in key mature markets, particularly North America, China and parts of Southeast Asia, where muted consumer sentiment, and broader geopolitical and economic uncertainties have constrained demand. Ongoing softness in affiliate and customer counts has also limited sales momentum.
Despite these pressures, Nu Skin’s earnings are expected to have benefited from improved operational efficiency and disciplined cost management under Project Accelerate. The company continues to drive structural savings through portfolio optimization, selling-expense realignment, and a transition to shared service and digital infrastructure models that reduce overhead.
These measures have supported consistent margin improvement, enabling the company to sustain profitability even amid declining sales volumes. Favorable mix shifts within the core Nu Skin business and prudent expense control are likely to have remained key earnings tailwinds in the third quarter.
While NUS’ third-quarter results are likely to reflect ongoing revenue pressure related to macro softness and business transition effects, the company’s improved cost structure, operational optimization and innovation-led initiatives are expected to have supported earnings growth and laid the foundation for a gradual recovery.
Earnings Whispers for NUS Stock
Our proven model does not conclusively predict an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Nu Skin has a Zacks Rank #3 and an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With the Favorable Combination
Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
Tapestry ((TPR - Free Report) ) currently has an Earnings ESP of +1.46% and a Zacks Rank of 2. TPR is likely to register bottom and top-line growth when it reports fiscal first-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.64 billion, which indicates 8.7% growth from the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for earnings stands at $1.25 per share, which implies a 22.6% increase from the year-ago quarter's actual. TPR has a trailing four-quarter earnings surprise of 10.3%, on average.
Under Armour ((UAA - Free Report) ) currently has an Earnings ESP of +22.22% and a Zacks Rank of 3. The company is likely to register a bottom-line decline when it reports second-quarter fiscal 2026 results. The Zacks Consensus Estimate for the quarterly earnings per share is pegged at 2 cents against earnings of 30 cents per share in the prior-year quarter.
The consensus mark for revenues is pegged at $1.31 billion, indicating a plunge of 6.7% from the figure reported in the prior-year quarter. UAA has a trailing four-quarter earnings surprise of 50.6%, on average.
The Campbell’s Company ((CPB - Free Report) ) currently has an Earnings ESP of +1.49% and a Zacks Rank of 3. The consensus mark for revenues is pegged at $2.67 billion, which calls for a decline of 3.8% from the figure reported in the year-ago quarter.
The Zacks Consensus Estimate for Campbell’s quarterly earnings per share of 74 cents implies a decrease of 16.9% from 89 cents reported in the year-ago quarter. CPB delivered a trailing four-quarter earnings surprise of 6.2%, on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock?
Key Takeaways
Nu Skin Enterprises, Inc. ((NUS - Free Report) ) is likely to register a decline in the top line when it reports third-quarter 2025 earnings on Nov. 6. The Zacks Consensus Estimate for revenues is pegged at $374.2 million, indicating a decrease of 13% from the prior-year reported figure.
The consensus mark for earnings has remained unchanged in the past 30 days at 30 cents per share, which suggests an increase of 76.5% from the year-ago quarter’s reported figure.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote
Things to Know Ahead of NUS’ Upcoming Results
Nu Skin is likely to face continued revenue pressure when it reports third-quarter 2025 results, reflecting persistent macroeconomic and operational headwinds. The company has been grappling with weakness in key mature markets, particularly North America, China and parts of Southeast Asia, where muted consumer sentiment, and broader geopolitical and economic uncertainties have constrained demand. Ongoing softness in affiliate and customer counts has also limited sales momentum.
Despite these pressures, Nu Skin’s earnings are expected to have benefited from improved operational efficiency and disciplined cost management under Project Accelerate. The company continues to drive structural savings through portfolio optimization, selling-expense realignment, and a transition to shared service and digital infrastructure models that reduce overhead.
These measures have supported consistent margin improvement, enabling the company to sustain profitability even amid declining sales volumes. Favorable mix shifts within the core Nu Skin business and prudent expense control are likely to have remained key earnings tailwinds in the third quarter.
While NUS’ third-quarter results are likely to reflect ongoing revenue pressure related to macro softness and business transition effects, the company’s improved cost structure, operational optimization and innovation-led initiatives are expected to have supported earnings growth and laid the foundation for a gradual recovery.
Earnings Whispers for NUS Stock
Our proven model does not conclusively predict an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Nu Skin has a Zacks Rank #3 and an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With the Favorable Combination
Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
Tapestry ((TPR - Free Report) ) currently has an Earnings ESP of +1.46% and a Zacks Rank of 2. TPR is likely to register bottom and top-line growth when it reports fiscal first-quarter results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.64 billion, which indicates 8.7% growth from the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for earnings stands at $1.25 per share, which implies a 22.6% increase from the year-ago quarter's actual. TPR has a trailing four-quarter earnings surprise of 10.3%, on average.
Under Armour ((UAA - Free Report) ) currently has an Earnings ESP of +22.22% and a Zacks Rank of 3. The company is likely to register a bottom-line decline when it reports second-quarter fiscal 2026 results. The Zacks Consensus Estimate for the quarterly earnings per share is pegged at 2 cents against earnings of 30 cents per share in the prior-year quarter.
The consensus mark for revenues is pegged at $1.31 billion, indicating a plunge of 6.7% from the figure reported in the prior-year quarter. UAA has a trailing four-quarter earnings surprise of 50.6%, on average.
The Campbell’s Company ((CPB - Free Report) ) currently has an Earnings ESP of +1.49% and a Zacks Rank of 3. The consensus mark for revenues is pegged at $2.67 billion, which calls for a decline of 3.8% from the figure reported in the year-ago quarter.
The Zacks Consensus Estimate for Campbell’s quarterly earnings per share of 74 cents implies a decrease of 16.9% from 89 cents reported in the year-ago quarter. CPB delivered a trailing four-quarter earnings surprise of 6.2%, on average.